May 25, 2017
Eli Lilly has retained The Chase Group to secure Medical Affairs Talent for their US Oncology Medical Affairs team for their promising CDK 4/6 molecule, Abemaciclib, in advanced breast cancer. This is a key leadership position within the medical group with responsibility to lead and build the US Abema Medical Affairs team. Lilly is focused on recruiting a physician that knows how to practice the art of medical affairs in a contemporary way to drive and deliver this product launch. For consideration, please contact Moira Newbanks at 913-663-3100 or moira@chasegroup.com.